Login / Signup

Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine.

Michael J LenaeusTamer M Gamal El-DinLige TongguNing ZhengWilliam A Catterall
Published in: Nature cardiovascular research (2023)
Keyphrases
  • structural basis
  • left ventricular
  • adverse drug
  • emergency department
  • heart failure
  • electronic health record